Robert A. Stewart
Equibles does not estimate personal net worth.
About Robert A. Stewart
Robert A. Stewart was last confirmed as CEO at Amneal Pharmaceuticals, Inc. (AMRX) in a filing dated March 23, 2020. The proxy statement of Amneal Pharmaceuticals, Inc. reports total compensation of $9,525,800 for Robert A. Stewart in fiscal 2019, including a base salary of $1,021,168. Disclosed compensation is on record for 2 fiscal years.
Affiliation history
-
Start not stated–2020-03-23
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Amneal Pharmaceuticals, Inc. (AMRX) | Former President & CEO | $1,021,168 | $9,525,800 |
| 2018 | Amneal Pharmaceuticals, Inc. (AMRX) | Former President & CEO | $634,615 | $11,683,805 |
Recent activity
No call appearances or filed executive changes recorded yet.